{
    "nctId": "NCT03814811",
    "briefTitle": "Circulating Osteocalcin-positive Cells in Breast Cancer Bone Metastasis",
    "officialTitle": "Circulating Osteocalcin-positive Cells as a Cell-Based Biomarker of Breast Cancer Bone Metastasis Progression",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms, Bone Metastases",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Progression of bone metastasis",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Stages 2A-4 breast cancer patients who are subject to adjuvant chemotherapy or radiotherapy\n* 20 years of age or greater\n* Female\n* Ability to understand the study objectives and willingness to sign written consent\n* ECOG status 0, 1 or 2\n\nExclusion Criteria:\n\n* History of primary cancer diagnosis in other sites than breast within 5 years\n* Diseases of bone metabolism including primary hyperparathyroidism, Paget's disease, osteomalacia, osteogenesis imperfecta\n* ECOG status 3 or 4\n* Retraction of written consent",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}